Right now, as far as I know, the results of the Barbados double blind study are to be released, and (my assumption) that an article in a scientific journal should supplement it.
And thanks for pointing out the statement by kingfisher, I can see where it _might_ be misinterpreted by someone who is not familiar with ADVR. However, now that it is pretty clear so we can move past that.
I have no idea what Dr. Hirschman's focus is at this point in time, they acquired, as you know, loans from abroad to implement research etc. I feel it may be sensible to assume that the increased number of trades the past few days MAY represent options being played out, thus the trades numbers without a significant price change.
Is there anything from your point of view as far as factual information, or what you may be hearing via any contacts you have, that you may want to share with us here.
It seems to me all of the negative spins that could be detrimental to ADVR have been spun out, by ADVR itself and also by the media. From where I am sitting, it's just a matter of time as to whether they will in fact come up with a marketable product (that generates income), or whether ADVR will become just another small biotech company that tried and failed. I have confidence in Dr. Hirschman and the plans they have made that are public. I simply await what's up the road and am not ready at this time to sell any shares until I see how this plays out.
It also seems to me, s., that day trading here has become more difficult as the price ranges seem to have stabilized somehwat and are not doing the erratic ups and downs we had previously. What this means is beyond my understanding...any thoughts?? |
